Request for Covid-19 Impact Assessment of this Report

Take Action
Pharmaceuticals

Global Pregabalin Market Size study, By Dosage Forms (Oral Capsule, Oral Solution, Oral Tablet, Extended Release), By Application (Epilepsy, Neuropathic Pain, Anxiety Disorder, Others), By Drug Class (Fibromyalgia Agents, Anticonvulsants, Others), By End-Users (Hospitals, Specialty Clinics, Homecare, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), and Regional Forecasts 2022-2028

  • BIZ4982928
  • 200 Pages
  • May 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
Global Pregabalin Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Pregabalin also called an anticonvulsant is an anti-epileptic medication, used for treatment of neurological conditions such as epilepsy and anxiety. It is also effective in treatment of nerve pain, such as burning, shooting, or stabbing pain. Pregabalin comes in capsules and oral solution. Rising prevalence of epilepsy worldwide and increasing application of Lyrica (Pregabalin) as well as growing healthcare expenditure are driving the growth for Pregabalin Market. For instance, according to World Health Organization (WHO) – as of 2021, around 5 million people are diagnosed with epilepsy every year. This disease is more prevalent in Low- & Middle-income countries. In low-income countries 139 per 100 000 people are affected by epilepsy. Whereas, in high income countries 49 per 100 000 people diagnosed with epilepsy each year . Moreover, in August 20219, The United States Food and Drug Administration granted approvals to nine pharma companies for development of first generic version of Lyrica (pregabalin). These nine companies were Alembic Pharmaceuticals, Alkem Laboratories, Amneal Pharmaceuticals, Dr Reddy’s Laboratories, InvaGen Pharmaceuticals, MSN Laboratories, Rising Pharmaceuticals, Sciegen Pharmaceuticals, and Teva Pharmaceuticals. Also, growing number of generic drug manufacturers and rising healthcare sector in emerging markets are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, side effects associated with Pregabalin impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Pregabalin Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to presence of leading market players and favorable government initiatives towards generic drug manufacturing in the region. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as increasing prevalence of neurological disorders and growing healthcare infrastructure in the region, would create lucrative growth prospects for the Pregabalin Market across the Asia Pacific region.

Major market players included in this report are:

Pfizer Inc. (US)

GlaxoSmithKline plc (UK)

Novartis AG (Switzerland)

Mylan N.V. (US)

Teva Pharmaceutical Industries Ltd. (Israel)

Sanofi (France)

F. Hoffmann-La Roche Ltd. (Switzerland)

Aurobindo Pharma (India)

Lupin (India)

Zydus Cadila (India)

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Dosage Forms

Oral Capsule

Oral Solution

Oral Tablet

Extended Release

By Application

Epilepsy

Neuropathic Pain

Anxiety Disorder

Others

By Drug Class

Fibromyalgia Agents

Anticonvulsants

Others

By End-Users

Hospitals

Specialty Clinics

Homecare

Others

By Distribution Channel

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020

Base year – 2021

Forecast period – 2022 to 2028

Target Audience of the Global Pregabalin Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)

1.2.1. Global Pregabalin Market, by Region, 2020-2028 (USD Million)

1.2.2. Global Pregabalin Market, by Application, 2020-2028 (USD Million)

1.2.3. Global Pregabalin Market, by Drug Class, 2020-2028 (USD Million)

1.2.4. Global Pregabalin Market, by Dosage Forms, 2020-2028 (USD Million)

1.2.5. Global Pregabalin Market, by End-Users, 2020-2028 (USD Million)

1.2.6. Global Pregabalin Market, by Distribution Channel, 2020-2028 (USD Million)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Pregabalin Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Pregabalin Market Dynamics

3.1. Pregabalin Market Impact Analysis (2020-2028)

3.1.1. Market Drivers

3.1.1.1. Rising prevalence of epilepsy worldwide.

3.1.1.2. Increasing application of Lyrica (Pregabalin).

3.1.1.3. Growing healthcare expenditure.

3.1.2. Market Challenges

3.1.2.1. Side effects associated with Pregabalin.

3.1.3. Market Opportunities

3.1.3.1. Growing number of generic drug manufacturers.

3.1.3.2. Rising healthcare sector in emerging Markets.

Chapter 4. Global Pregabalin Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

4.5. Top investment opportunity

4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1.1. Assessment of the overall impact of COVID-19 on the industry

5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Pregabalin Market, by Application

6.1. Market Snapshot

6.2. Global Pregabalin Market by Application, Performance - Potential Analysis

6.3. Global Pregabalin Market Estimates & Forecasts by Application 2018-2028 (USD Million)

6.4. Pregabalin Market, Sub Segment Analysis

6.4.1. Epilepsy

6.4.2. Neuropathic Pain

6.4.3. Anxiety Disorder

6.4.4. Others

Chapter 7. Global Pregabalin Market, by Drug Class

7.1. Market Snapshot

7.2. Global Pregabalin Market by Drug Class, Performance - Potential Analysis

7.3. Global Pregabalin Market Estimates & Forecasts by Drug Class 2018-2028 (USD Million)

7.4. Pregabalin Market, Sub Segment Analysis

7.4.1. Fibromyalgia Agents

7.4.2. Anticonvulsants

7.4.3. Others

Chapter 8. Global Pregabalin Market, by Dosage Forms

8.1. Market Snapshot

8.2. Global Pregabalin Market by Dosage Forms, Performance - Potential Analysis

8.3. Global Pregabalin Market Estimates & Forecasts by Dosage Forms 2018-2028 (USD Million)

8.4. Pregabalin Market, Sub Segment Analysis

8.4.1. Oral Capsule

8.4.2. Oral Solution

8.4.3. Oral Tablet

8.4.4. Extended Release

Chapter 9. Global Pregabalin Market, by End-Users

9.1. Market Snapshot

9.2. Global Pregabalin Market by End-Users, Performance - Potential Analysis

9.3. Global Pregabalin Market Estimates & Forecasts by End-Users 2018-2028 (USD Million)

9.4. Pregabalin Market, Sub Segment Analysis

9.4.1. Hospitals

9.4.2. Specialty Clinics

9.4.3. Homecare

9.4.4. Others

Chapter 10. Global Pregabalin Market, by Distribution Channel

10.1. Market Snapshot

10.2. Global Pregabalin Market by Distribution Channel, Performance - Potential Analysis

10.3. Global Pregabalin Market Estimates & Forecasts by Distribution Channel 2018-2028 (USD Million)

10.4. Pregabalin Market, Sub Segment Analysis

10.4.1. Hospital Pharmacy

10.4.2. Retail Pharmacy

10.4.3. Online Pharmacy

10.4.4. Others

Chapter 11. Global Pregabalin Market, Regional Analysis

11.1. Pregabalin Market, Regional Market Snapshot

11.2. North America Pregabalin Market

11.2.1. U.S. Pregabalin Market

11.2.1.1. Application estimates & forecasts, 2018-2028

11.2.1.2. Drug Class estimates & forecasts, 2018-2028

11.2.1.3. Dosage Forms estimates & forecasts, 2018-2028

11.2.1.4. End-Users estimates & forecasts, 2018-2028

11.2.1.5. Distribution Channel estimates & forecasts, 2018-2028

11.2.2. Canada Pregabalin Market

11.3. Europe Pregabalin Market Snapshot

11.3.1. U.K. Pregabalin Market

11.3.2. Germany Pregabalin Market

11.3.3. France Pregabalin Market

11.3.4. Spain Pregabalin Market

11.3.5. Italy Pregabalin Market

11.3.6. Rest of Europe Pregabalin Market

11.4. Asia-Pacific Pregabalin Market Snapshot

11.4.1. China Pregabalin Market

11.4.2. India Pregabalin Market

11.4.3. Japan Pregabalin Market

11.4.4. Australia Pregabalin Market

11.4.5. South Korea Pregabalin Market

11.4.6. Rest of Asia Pacific Pregabalin Market

11.5. Latin America Pregabalin Market Snapshot

11.5.1. Brazil Pregabalin Market

11.5.2. Mexico Pregabalin Market

11.6. Rest of The World Pregabalin Market

Chapter 12. Competitive Intelligence

12.1. Top Market Strategies

12.2. Company Profiles

12.2.1. Pfizer Inc. (US)

12.2.1.1. Key Information

12.2.1.2. Overview

12.2.1.3. Financial (Subject to Data Availability)

12.2.1.4. Product Summary

12.2.1.5. Recent Developments

12.2.2. GlaxoSmithKline plc (UK)

12.2.3. Novartis AG (Switzerland)

12.2.4. Mylan N.V. (US)

12.2.5. Teva Pharmaceutical Industries Ltd. (Israel)

12.2.6. Sanofi (France)

12.2.7. F. Hoffmann-La Roche Ltd. (Switzerland)

12.2.8. Aurobindo Pharma (India)

12.2.9. Lupin (India)

12.2.10. Zydus Cadila (India)

Chapter 13. Research Process

13.1. Research Process

13.1.1. Data Mining

13.1.2. Analysis

13.1.3. Market Estimation

13.1.4. Validation

13.1.5. Publishing

13.2. Research Attributes

13.3. Research Assumption

List of Tables

TABLE 1. Global Pregabalin Market, report scope

TABLE 2. Global Pregabalin Market estimates & forecasts by Region 2018-2028 (USD Million)

TABLE 3. Global Pregabalin Market estimates & forecasts by Application 2018-2028 (USD Million)

TABLE 4. Global Pregabalin Market estimates & forecasts by Drug Class 2018-2028 (USD Million)

TABLE 5. Global Pregabalin Market estimates & forecasts by Dosage Forms 2018-2028 (USD Million)

TABLE 6. Global Pregabalin Market estimates & forecasts by End-Users 2018-2028 (USD Million)

TABLE 7. Global Pregabalin Market estimates & forecasts by Distribution Channel 2018-2028 (USD Million)

TABLE 8. Global Pregabalin Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 9. Global Pregabalin Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 10. Global Pregabalin Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 11. Global Pregabalin Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 12. Global Pregabalin Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 13. Global Pregabalin Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 14. Global Pregabalin Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 15. Global Pregabalin Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 16. Global Pregabalin Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 17. Global Pregabalin Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 18. U.S. Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 19. U.S. Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 20. U.S. Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 21. Canada Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 22. Canada Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 23. Canada Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 24. UK Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 25. UK Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 26. UK Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 27. Germany Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 28. Germany Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 29. Germany Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 30. RoE Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 31. RoE Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 32. RoE Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 33. China Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 34. China Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 35. China Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 36. India Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 37. India Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 38. India Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 39. Japan Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 40. Japan Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 41. Japan Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 42. RoAPAC Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 43. RoAPAC Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 44. RoAPAC Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 45. Brazil Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 46. Brazil Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 47. Brazil Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 48. Mexico Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 49. Mexico Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 50. Mexico Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 51. RoLA Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 52. RoLA Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 53. RoLA Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 54. Row Pregabalin Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 55. Row Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 56. Row Pregabalin Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 57. List of secondary sources, used in the study of global Pregabalin Market

TABLE 58. List of primary sources, used in the study of global Pregabalin Market

TABLE 59. Years considered for the study

TABLE 60. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
View Details
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370
View Details
Global Orphan Drugs Market by Disease Type (Oncologic Diseases, Metabolic Diseases, Hematologic and Immunologic Diseases, Infectious Diseases, Neurologic Diseases and Other Rare Diseases), Indication (Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Cystic Fibrosis, Glioma, Pancreatic Cancer, Ovarian Cancer, Multiple Myeloma, Duchenne Muscular Dystrophy, Graft vs Host Disease, Renal Cell Carcinoma and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022

The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...

  • Publish Date: April 24, 2017
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research